Can duloxetine cause a cold sensation in the eyes?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 30, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Duloxetine and Cold Eye Sensation

Duloxetine does not cause a "cold sensation" in the eyes as a recognized adverse effect, but it can significantly affect ocular health through dry eye syndrome and, rarely, acute angle-closure glaucoma.

Primary Ocular Effects of Duloxetine

The FDA-approved drug label for duloxetine does not list "cold eyes" or cold sensation in the eyes as a documented adverse effect 1. However, duloxetine has well-documented effects on the ocular surface that may create uncomfortable sensations:

Dry Eye Syndrome (Most Common)

Duloxetine significantly reduces tear production and disrupts the ocular surface, which may manifest as various uncomfortable sensations including burning, grittiness, or potentially cold-like feelings.

  • Research demonstrates that duloxetine users have markedly lower Schirmer test results (11.41 ± 6.73 mm) compared to controls (22.53 ± 4.98 mm), indicating substantially reduced tear production 2
  • Among antidepressants studied, duloxetine produced the lowest tear parameters, with significantly worse outcomes than even venlafaxine (another SNRI) 2, 3
  • The mechanism appears related to both serotonin and noradrenaline blockade, not just anticholinergic effects 2, 3

Clinical Pitfall: Patients may describe dry eye symptoms in various ways—including sensations of coldness, burning, or foreign body sensation. What feels "cold" to one patient may be their interpretation of ocular surface dryness or exposure.

Angle-Closure Glaucoma (Rare but Serious)

The FDA label specifically warns about angle-closure glaucoma risk, noting that duloxetine can cause mild pupillary dilation leading to acute angle-closure in susceptible individuals 1. Multiple case reports document bilateral acute angle-closure glaucoma following duloxetine initiation 4, 5.

Key warning signs include:

  • Eye pain
  • Changes in vision
  • Swelling or redness in or around the eye 1

Anterior Chamber Changes

Recent research shows duloxetine causes statistically significant decreases in anterior chamber parameters within 3 months, though these may not be clinically significant in open-angle eyes 6.

Clinical Recommendations

If a patient reports "cold eyes" on duloxetine:

  1. Evaluate for dry eye syndrome first (most likely explanation):

    • Perform Schirmer test without anesthesia
    • Assess tear breakup time
    • Examine corneal surface for staining
    • Consider tear meniscus evaluation
  2. Rule out angle-closure glaucoma if accompanied by:

    • Eye pain
    • Visual changes
    • Headache
    • Nausea
    • Perform immediate IOP measurement and gonioscopy
  3. Management approach:

    • For dry eye: Initiate artificial tears, consider punctal plugs if severe
    • Monitor symptoms closely, especially in first 3 months
    • Consider alternative antidepressant if symptoms are intolerable (SSRIs like escitalopram show better ocular surface profiles than duloxetine) 2

The sensation of "cold eyes" is not a standard adverse effect terminology but likely represents the patient's description of dry eye symptoms, which are well-documented and significant with duloxetine use 2, 3.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.